Home » FDA Says All Off-Label Communications Can Fall Within Regulatory Purview
FDA Says All Off-Label Communications Can Fall Within Regulatory Purview
The First Amendment does not preclude drugmakers from FDA’s oversight of off-label communication even if what they say is truthful, the agency said.
The agency has the authority to regulate all off-label communication to ensure unapproved drugs do not reach the market, according to an FDA memo.
The FDA cannot explicitly restrict communication on off-label uses, but it has the power to regulate the introduction of unapproved or misbranded drugs and a company’s promotions might be relevant to enforcement.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May